Actively Recruiting
Study of Coagulation, Inflammation, and Blood Vessel Changes in Adults with Chronic Liver Diseases
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2024-08-01
360
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Chronic liver diseases cause significant health problems and over 150,000 deaths annually in Europe. These conditions affect working-age individuals and greatly impact quality of life and the economy. Researchers are investigating the roles of blood clotting problems, inflammation, and blood vessel changes in the development and worsening of these diseases to improve patient care and outcomes. Participants include people with chronic liver disease at various stages, from no cirrhosis to advanced liver failure, as well as control participants without liver disease. The study collects blood samples from all participants on the day they join to analyze factors related to blood clotting and disease progression. This observational study aims to better understand how coagulation contributes to chronic liver disease and its complications. During the study, participants undergo blood draws at inclusion to measure multiple blood clotting factors and related markers over a period of up to 10 years. Researchers will assess abnormalities in these factors in patients at different disease stages and compare them to controls. The long-term monitoring will help clarify the role of coagulation in disease development and support improved management strategies.
CONDITIONS
Brief Title
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
Research Team
P
Pierre Emmanuel Rautou
A
Alix Riescher-Tuczkiewicz
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here